USANA Health Sciences, Inc. (NYSE:USNA) Director Myron W. Wentz sold 1,985 shares of the company’s stock in a transaction dated Thursday, November 9th. The stock was sold at an average price of $66.01, for a total value of $131,029.85. Following the completion of the sale, the director now directly owns 12,011,418 shares of the company’s stock, valued at approximately $792,873,702.18. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
USANA Health Sciences, Inc. (USNA) opened at $65.85 on Tuesday. The company has a market capitalization of $1,569.11, a PE ratio of 17.30 and a beta of 1.07. USANA Health Sciences, Inc. has a 1-year low of $52.55 and a 1-year high of $71.00.
USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings results on Tuesday, October 24th. The company reported $1.02 EPS for the quarter, beating analysts’ consensus estimates of $0.91 by $0.11. The firm had revenue of $261.77 million during the quarter, compared to the consensus estimate of $259.52 million. USANA Health Sciences had a return on equity of 26.38% and a net margin of 8.79%. USANA Health Sciences’s revenue for the quarter was up 3.0% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.40 earnings per share. analysts anticipate that USANA Health Sciences, Inc. will post 3.7 earnings per share for the current fiscal year.
USANA Health Sciences declared that its Board of Directors has approved a share repurchase plan on Tuesday, July 25th that allows the company to repurchase $64.60 million in shares. This repurchase authorization allows the company to reacquire up to 46% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company’s board believes its stock is undervalued.
TRADEMARK VIOLATION WARNING: “USANA Health Sciences, Inc. (USNA) Director Myron W. Wentz Sells 1,985 Shares of Stock” was posted by Transcript Daily and is the sole property of of Transcript Daily. If you are reading this piece of content on another site, it was stolen and reposted in violation of United States and international copyright & trademark law. The original version of this piece of content can be accessed at https://transcriptdaily.com/2017/11/14/usana-health-sciences-inc-usna-director-myron-w-wentz-sells-1985-shares-of-stock.html.
Institutional investors and hedge funds have recently modified their holdings of the stock. Northern Trust Corp boosted its holdings in USANA Health Sciences by 10.5% in the second quarter. Northern Trust Corp now owns 177,630 shares of the company’s stock valued at $11,386,000 after purchasing an additional 16,948 shares during the last quarter. American International Group Inc. boosted its holdings in USANA Health Sciences by 7.1% in the first quarter. American International Group Inc. now owns 6,392 shares of the company’s stock valued at $368,000 after purchasing an additional 422 shares during the last quarter. Trust Co. of Vermont boosted its holdings in USANA Health Sciences by 482.7% in the third quarter. Trust Co. of Vermont now owns 4,708 shares of the company’s stock valued at $272,000 after purchasing an additional 3,900 shares during the last quarter. Schroder Investment Management Group lifted its holdings in USANA Health Sciences by 9.0% during the 2nd quarter. Schroder Investment Management Group now owns 572,186 shares of the company’s stock worth $36,734,000 after buying an additional 47,448 shares during the last quarter. Finally, FMR LLC lifted its holdings in USANA Health Sciences by 3.9% during the 2nd quarter. FMR LLC now owns 1,598,143 shares of the company’s stock worth $102,441,000 after buying an additional 60,033 shares during the last quarter. 44.54% of the stock is owned by hedge funds and other institutional investors.
Several equities research analysts have recently weighed in on the company. BidaskClub downgraded USANA Health Sciences from a “sell” rating to a “strong sell” rating in a research report on Monday, July 31st. Pivotal Research upped their target price on USANA Health Sciences from $70.00 to $80.00 and gave the stock a “buy” rating in a research report on Wednesday, October 25th.
About USANA Health Sciences
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.
Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.